Beatrice de Vos

Beatrice De Vos serves as the Chief Medical Officer at EXO Biologics since January 2021 and has held a position as a clinical research expert with the World Health Organization since 2019. With extensive experience in the pharmaceutical industry, Beatrice De Vos has contributed to vaccine development as an advisor at the TuBerculosis Vaccine Initiative since 2016 and established Bejamad sprl/bvba in 2007, providing strategic advice in clinical, regulatory, and medical affairs. Previous roles include Chief Medical Officer at NOVADIP Biosciences S.A. and PDC*line Pharma, and Chairman of the Board of Directors at BioTech Tools. Educational credentials include a medical degree from KUL, a PhD in medical sciences from UIAntwerpen, and specialization in pharmaceutical sciences.